| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ruffo Frank is a Chief Financial Officer at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $908K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Sell | 12,823 | $15.55 | $199,334.82 | -6.0% | -3.3% | -50.7% | |
| Feb 9, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Sell | 1,388 | $12.66 | $17,568.47 | -0.8% | -12.7% | +8.8% | |
| Jun 2, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 15,037 | $21.64 | $325,382.63 | -4.2% | -25.4% | -33.4% | |
| Apr 26, 2021 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Sell | 87,339 | $26.45 | $2,310,106.14 | -9.1% | -42.0% | -46.0% | |
| May 7, 2018 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Buy | 1,250 | $18.22 | $22,775.00 | +0.8% | - | - | |
| Apr 6, 2018 | ACRS Aclaris Therapeutics, Inc. | Chief Financial Officer | Buy | 1,250 | $16.59 | $20,737.50 | +0.8% | - | - |